Volume 68 Received 15 September 2012 | ||||||||||
| ||||||||||
2N4,N5](trifluoroacetato-
O)silver(I)aTianjin Entry-Exit Inspection and Quarantine Bureau, Tianjin 300201, People's Republic of China, and bDisease Hospital of TianJin City, Tianjin 300201, People's Republic of China
Correspondence e-mail: yanjiuyuan_lee@126.com
In the asymmetric unit of the title compound, [Ag(C10H6N4)2(CF3CO2)], there two mononuclear but slightly different complex units. In each, two
2N:N-chelating 5-(pyridin-2-yl)pyrazine-2-carbonitrile ligands surround the AgI atom, giving an N4O square-pyramidal coordination geometry with one trifluoroacetate O atom at the apex. The difference between the two lies in the Ag-N bond lengths: in one complex, three normal [range 2.272 (5)-2.552 (5) Å] and one long [2.706 (4) Å] and in the second, two normal [2.254 (5) and 2.290 (5) Å] and two long [2.647 (5) and 2.675 (5) Å] are present. Short intermolecular F
F contacts [2.586 (4) Å] and weak
-
stacking interactions [minimum ring centroid separation 3.836 (5) Å] between pyridyl and pyrazinyl rings connect the complex units, forming columns which extend along the b-axis direction.
For metal complexes with pyridyl-based ligands, see: Wang et al. (2009
); O'Keeffe & Yaghi (2012
); Choudhury et al. (2002
). For complexes with 5-(pyridin-2-yl)pyrazine-2-carbonitrile, see: Wang et al. (2010
); Zhang & Yang (2011
). For van der Waals radii, see: Pauling (1960
).
|
|
Data collection: APEX2 (Bruker 2007
); cell refinement: APEX2 and SAINT (Bruker 2007
); data reduction: SAINT; program(s) used to solve structure: SHELXS97 (Sheldrick, 2008
); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008
); molecular graphics: SHELXTL (Sheldrick, 2008
); software used to prepare material for publication: SHELXTL and PLATON (Spek, 2009
).
Supplementary data and figures for this paper are available from the IUCr electronic archives (Reference: ZS2235 ).
The authors are grateful for financial support from the Science and Technology Program, Tianjin Municipal Commission.
Bruker (2007). APEX2, SADABS and SAINT. Bruker AXS Inc., Madison,Wisconsin, USA.
Choudhury, A. R., Urs, U. K., Nagarajan, K. & Row, T. N. G. (2002). J. Mol. Struct. 605, 71-75.
![[ChemPort]](../../../../../../logos/chemportborder.gif)
Flack, H. D. (1983). Acta Cryst. A39, 876-881.
![[details]](../../../../../../a/graphics/details.gif)
O'Keeffe, M. & Yaghi, O. M. (2012). Chem. Rev. 112, 675-702.
![[PubMed]](../../../../../../logos/pubmedborder.gif)
Pauling, L. (1960). The Nature of the Chemical Bond, p. 260. New York: Cornell University Press.
Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.
![[details]](../../../../../../a/graphics/details.gif)
Spek, A. L. (2009). Acta Cryst. D65, 148-155.
![[details]](../../../../../../d/graphics/details.gif)
Wang, Z.-J., Zhang, F. & Wan, C.-Q. (2010). Acta Cryst. E66, m1232-m1233.
![[details]](../../../../../../e/graphics/details.gif)
Wang, Y., Zhao, X.-Q., Shi, W., Cheng, P., Liao, D.-Z. & Yan, S.-P. (2009). Cryst. Growth Des. 9, 2137-2145.
![[ChemPort]](../../../../../../logos/chemportborder.gif)
Zhang, F. & Yang, Y.-L. (2011). Acta Cryst. E67, m1863.
![[details]](../../../../../../e/graphics/details.gif)